About Cell Signalling Cascade
The MAPK (Mitogen-Activated Protein Kinase) cascade is one of the most conserved intracellular signalling pathways in eukaryotic cells, translating extracellular growth factor signals into gene expression changes that drive cell proliferation, differentiation, and survival. The canonical pathway proceeds: a growth factor ligand binds a receptor tyrosine kinase → activated receptor recruits and activates Ras (a small GTPase) → Ras activates Raf kinase → Raf phosphorylates and activates MEK → MEK phosphorylates and activates ERK. Active ERK translocates to the nucleus and phosphorylates transcription factors. The cascade is a signal amplifier: one activated receptor can stimulate thousands of ERK molecules within minutes.
The simulation models the phosphorylation and dephosphorylation dynamics of each tier using Michaelis-Menten kinetics. You can adjust ligand concentration (the input signal), phosphatase activity (which opposes the kinases), and the cooperativity of each step to see how the cascade switches between graded and ultrasensitive (switch-like) responses.
Frequently Asked Questions
What is phosphorylation and why does it activate proteins?
Phosphorylation is the addition of a phosphate group (PO₄³⁻) to a serine, threonine, or tyrosine residue of a protein, catalysed by kinase enzymes using ATP as the phosphate donor. The added negative charge and bulk of the phosphate group alter the protein's conformation, often exposing an active site or creating a docking site for other proteins. It is reversible: phosphatase enzymes remove the phosphate group, switching the protein back off. This on/off reversibility makes phosphorylation the cell's primary signalling switch.
What is the Ras-Raf-MEK-ERK pathway?
The RAS-RAF-MEK-ERK pathway (also called the MAPK/ERK pathway) is a three-tier kinase cascade. Ras is a GTPase that cycles between inactive GDP-bound and active GTP-bound states; receptor activation recruits GEF proteins (guanine nucleotide exchange factors) that load GTP onto Ras. Active Ras binds and recruits Raf to the membrane, activating it. Raf phosphorylates MEK on two serine residues; MEK in turn phosphorylates ERK on both a threonine and a tyrosine residue — a dual phosphorylation requirement that makes ERK activation ultrasensitive.
What is signal ultrasensitivity?
Ultrasensitivity describes a switch-like response where a small increase in input near a threshold causes a large, steep increase in output — analogous to a light switch rather than a dimmer. The Goldbeter-Koshland mechanism shows that a protein requiring dual phosphorylation (like ERK) can be ultrasensitive even if each individual phosphorylation step is graded. The Hill coefficient n > 1 quantifies cooperativity; ERK activation in living cells has been measured with effective n ≈ 3–5, enabling near-digital on/off responses.
How do mutations in the MAPK pathway cause cancer?
Activating mutations in RAS genes are among the most common oncogenic mutations in human cancer, found in ~30% of all tumours (particularly KRAS in pancreatic, lung, and colorectal cancers). A single point mutation (e.g., Gly12Val) locks Ras in its GTP-bound active state by abolishing its GTPase activity, causing constitutive downstream signalling regardless of ligand input. The BRAF V600E mutation — found in ~60% of melanomas — similarly constitutively activates Raf and downstream ERK.
What are kinase inhibitors and how do they work?
Kinase inhibitors are drugs that block the ATP-binding site of a kinase, preventing it from phosphorylating its substrates. The first successful example was imatinib (Gleevec), which inhibits the BCR-ABL kinase in chronic myeloid leukaemia and transformed the disease from terminal to manageable. MAPK pathway drugs include vemurafenib (BRAF inhibitor) and trametinib (MEK inhibitor), used in BRAF-mutant melanoma. A major challenge is resistance: cancer cells often reactivate the pathway by upregulating alternative inputs.
What is negative feedback in cell signalling?
Negative feedback occurs when the output of a pathway suppresses its own upstream activators, reducing sensitivity and preventing runaway activation. ERK itself phosphorylates and inhibits SOS (the GEF that activates Ras), Raf, and MEK1, creating multiple negative feedback loops. These loops are responsible for the transient "pulse-then-adapt" dynamics seen in many growth factor responses, and they create the adaptation memory that allows cells to sense changes in signal rather than absolute signal level.
How is the MAPK cascade different from a simple amplifier?
A simple amplifier multiplies a signal by a fixed gain. The MAPK cascade is a switch-like amplifier whose gain depends on operating conditions: near the threshold, the cascade is highly sensitive (high gain) but above or below threshold it saturates. Furthermore, the cascade can be tuned by scaffold proteins that hold Raf, MEK, and ERK together (increasing effective local concentration and specificity) and by the balance of kinase and phosphatase activities that set the switching threshold.
What is crosstalk between signalling pathways?
Signalling pathways are not isolated: many kinases phosphorylate substrates in multiple pathways, and second messengers like Ca²⁺ and cAMP can modulate MAPK activity. For example, the PI3K/Akt pathway cross-activates Raf in some contexts, and cAMP-dependent PKA can either activate or inhibit Raf depending on cell type. This crosstalk means that drugs targeting one pathway often have off-target effects on others, complicating cancer therapy.
What is ligand concentration-response and EC50?
The EC50 is the ligand concentration that produces half the maximum response. For a simple receptor binding to ligand with dissociation constant Kᴷ, the fraction of occupied receptors follows a hyperbolic (Michaelis-Menten) curve: f = [L]/([L]+Kᴷ), so EC50 = Kᴷ. With signal amplification through the MAPK cascade, the apparent EC50 for ERK activation can be much lower than the receptor Kᴷ — a cell can respond detectably to very low ligand concentrations because even a few activated receptors drive many ERK molecules.
How does the simulation handle phosphatase activity?
Phosphatases are modelled as constitutively active enzymes that continuously dephosphorylate each tier of the cascade (acting on active Raf, phospho-MEK, and doubly phospho-ERK). In steady state, ERK activation level is determined by the balance between kinase activity (driven by upstream signal) and phosphatase activity. Increasing phosphatase activity raises the threshold for ERK activation and reduces its peak amplitude; decreasing it makes the pathway more sensitive and can push the cascade into an "always on" state even at low ligand concentrations.